Document is current
Any future updates will be listed below
-
Authors
Meyer, David H.
Mejia, Gabriel
Molière, Adrian
Wangprapa, Panupong
Khunlertkit, Tanawat
Teekakirikul, Polakit
Ewald, Collin Y. https://orcid.org/0000-0003-1166-4171
Viecelli, Claudio https://orcid.org/0000-0002-9093-4864
-
Funding
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (190072)
- License Information
-
More Information
Article History
Received: 25 December 2024
Accepted: 4 November 2025
First Online: 10 December 2025
Declarations
:
: The authors have no competing interests to declare. CYE declares to be a co-founder and shareholder of Avea Life AG and Lichi3 GmbH and is employed by Novartis. CV is employed by Keyoniq Switzerland AG. CV serves as a scientific advisor to VitalLife Scientific Wellness Center, Thailand, in the field of exercise physiology. This advisory role is unrelated to the current research and did not influence the study design, data collection, analysis, or interpretation of results. DM, and GM are consultants of Keyoniq Switzerland AG. PW, TK, and PT are employed by VitalLife Scientific Wellness Center, Thailand.
